J9022 Injection, atezolizumab,10 milligrams
Also known as: Tecentriq, Atezolizumab
Atezolizumab administered by injection at 10 milligrams per dose; a programmed death-ligand 1 inhibitor immunotherapy used for various malignancies.
In Plain Language
Immune checkpoint inhibitor injection; Cancer immunotherapy
Clinical Context
Used for non-small cell lung cancer, urothelial carcinoma, and other cancers. Blocks PD-L1 interaction to enhance immune response.
RVU Information
CPT J9022 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9022?
CPT J9022 (Injection, atezolizumab,10 milligrams) is a J Codes (Drugs) code. Atezolizumab administered by injection at 10 milligrams per dose; a programmed death-ligand 1 inhibitor immunotherapy used for various malignancies.
How is J9022 administered?
CPT J9022 is administered by a healthcare provider, typically via injection or infusion. Used for non-small cell lung cancer, urothelial carcinoma, and other cancers. Blocks PD-L1 interaction to enhance immune response. It is used by Oncology, Pulmonology, Immunology.
When is CPT J9022 used?
Used for non-small cell lung cancer, urothelial carcinoma, and other cancers. Blocks PD-L1 interaction to enhance immune response.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.